Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,437 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07213297Recruiting
Program for hereditary transthyretin amyloidosis
This trial is for people with a specific inherited form of amyloidosis caused by a change in the TTR gene. It offers a comprehensive care program to help manage this rare condition.
Canuelas, Buenos AiresAges 18 years+ - NCT07218445RecruitingPhase 4
Tirzepatide for hot flashes in post-menopausal women with obesity
This study tests whether tirzepatide, a weekly injection, can reduce bothersome hot flashes and slow biological aging in post-menopausal women with obesity. It also includes a personalized diet and exercise plan.
Jacksonville, FloridaAges 46–60 - NCT07215039Enrolling by invitation
Cancer screening awareness for women in prison
This study aims to improve cancer knowledge and screening among women incarcerated at Gadsden Correctional Facility in Florida. It may help you understand your cancer risks and get the screenings you need.
Jacksonville, FloridaAges 18 years+ - NCT07217405RecruitingPhase 4
Radiation or steroid shot for hand osteoarthritis pain
This trial compares low-dose radiation therapy to a corticosteroid injection to see which works better for hand osteoarthritis pain. It's for people 50 and older with moderate to severe hand OA who have significant pain when using their hand.
Rochester, MinnesotaAges 50 years+ - NCT07217665Enrolling by invitationPhase 2
AADvac1 vaccine for progressive supranuclear palsy
This trial tests a vaccine called AADvac1 for people with progressive supranuclear palsy (PSP), a brain condition that affects movement and thinking. The study wants to see if the vaccine can slow the disease down.
San Francisco, CaliforniaAges 41–86 - NCT07213466RecruitingPhase 4
Personalized weight-loss medication for bipolar disorder
This study wants to see if a personalized approach with FDA-approved weight-loss medications can help people with bipolar disorder who are overweight or have obesity, while staying on their mood stabilizer treatment. It might be a good fit if you have bipolar disorder and struggle with your weight.
Rochester, MinnesotaAges 18–65 - NCT07218705Recruiting
MCG scan study for cardiac amyloidosis
This study uses a new type of heart scan (MCG) to help understand cardiac amyloidosis. It may help doctors learn more about the condition without needing invasive tests.
Rochester, MinnesotaAges 18 years+ - NCT07212933RecruitingPhase 2
RAK cell therapy for advanced stomach cancer
This trial tests a new type of immune cell therapy called RAK cells for people with late-stage stomach cancer that has spread and stopped responding to standard treatments. The goal is to see if it is safe and helps control the cancer.
Beijing, Beijing MunicipalityAges 18–70 - NCT07218952Enrolling by invitation
Radiation therapy for Parkinson's disease
This trial tests if a targeted radiation therapy can help people with early-stage Parkinson's disease that affects only one side of the body. It aims to see if this treatment can slow down the disease and improve symptoms.
Rochester, MinnesotaAges 45–70 - NCT07212244Recruiting
Focused ultrasound for hard-to-treat tremor
This study uses a focused ultrasound treatment guided by MRI to calm hand tremors in people with essential tremor that hasn't responded to medication. It aims to improve daily life by reducing shaking without the need for surgery.
Toronto, OntarioAges 22 years+ - NCT07213167Recruiting
Low contrast vision test for different lens implants
This trial checks how well you see in low light and low contrast after having cataract surgery with specific lens implants. It helps doctors understand which lenses work best in dim conditions.
Bakersfield, CaliforniaAges 22 years+ - NCT07216469Recruiting
Heart Stiffness in Amyloidosis: A Study Using MRI
This study uses a special MRI scan to measure how stiff the heart muscle is in people with cardiac amyloidosis. The goal is to better understand the condition and potentially guide future treatments.
Rochester, MinnesotaAges 20 years+ - NCT07212491Enrolling by invitation
Gentle cell sampling to check for early signs of esophageal cancer
This study tests less invasive ways to detect high-grade dysplasia (very abnormal cells) and esophageal cancer in people with Barrett's esophagus, a condition that can increase cancer risk. It looks for these changes using cell samples taken during a routine endoscopy, which may be quicker and more comfortable than standard biopsies.
Scottsdale, ArizonaAges 18–90 - NCT07218939Recruiting
Collecting extra samples during lung procedures
This trial collects extra samples (like tissue or fluid) that are left over from your routine lung procedure. It helps researchers study lung health without any extra risk to you.
Houston, TexasAges 18 years+ - NCT07215910RecruitingPhase 3
Testing vorasidenib with temozolomide after radiation for advanced brain cancer
This trial tests whether adding the targeted drug vorasidenib to standard chemotherapy (temozolomide) after radiation helps people with a specific type of advanced brain cancer called IDH-mutant astrocytoma. It is for patients who have not had previous treatments like chemotherapy or radiation and whose tumors have certain genetic features.
Bakersfield, CaliforniaAges 12 years+ - NCT07220382RecruitingPhase 4
Botox injections before large hernia surgery
This trial tests if getting Botox shots in the belly muscles before hernia surgery makes the repair easier and more successful. It is for adults who need a planned, open surgery for a large ventral hernia.
Cleveland, OhioAges 18 years+ - NCT07214610Recruiting
Improving breast cancer outcomes in North Carolina
This study looks at why some women with invasive breast cancer do better than others. It combines information from biology, medical history, and lifestyle to find ways to improve care and outcomes.
Chapel Hill, North CarolinaAges 20–74 - NCT07215494Recruiting
AL Amyloidosis: Testing for Hidden Disease After Transplant
This study looks for 'minimal residual disease' (tiny traces of amyloid after treatment) in people with AL amyloidosis who have had a stem cell transplant. It helps doctors understand if more treatment is needed.
Beijing, Beijing MunicipalityAges 18–70 - NCT05508347RecruitingPhase 2
Testing a new antibody with chemo for locally advanced throat cancer
This study tests nituzumab (a targeted antibody) added to standard induction chemotherapy versus placebo plus chemotherapy. It aims to improve tumor control and safety for people with locally advanced nasopharyngeal (throat) cancer.
Chengdu, SichuanAges 18–70 - NCT06357741Recruiting
Desuzumab for knee osteoarthritis
This study tests a new medicine called Desuzumab for knee osteoarthritis. It looks at whether the medicine can help reduce pain and improve joint function.
Wuhan, HubeiAges 45–75 - NCT06918262Recruiting
MRD-guided local therapy for oligometastatic breast cancer
This study is looking at a test called MRD (minimal residual disease) to see if it can guide decisions about local treatments (like surgery or radiation) for people with breast cancer that has spread to a few spots. It may help doctors know when to use these treatments and when to wait.
Changchun, JilinAges Any age - NCT06918769Recruiting
Using a new urine test to reduce unnecessary antibiotics for bladder infections
This study tests a new urine test (the UF-5000) to see if it can help doctors decide who really needs antibiotics for a bladder infection. The goal is to avoid giving antibiotics when they are not needed.
Hong Kong, Hong KongAges 18–99 - NCT04300101Recruiting
Study of a blood- and tissue-based index in large B-cell lymphoma
This study looks at a “Mixed Molecular Clinical Index” (MMCI), which combines test results from lymphoma tissue and clinical information. It aims to help better understand how diffuse large B-cell lymphoma behaves and how patients may respond to standard first-line treatment.
Meldola, FCAges 18 years+ - NCT06431243RecruitingPhase 1/Phase 2
Purinostat Mesylate for advanced solid tumors
This trial tests a new drug called Purinostat Mesylate, either alone or combined with other drugs, in people with advanced solid tumors (including breast cancer) that have not responded to standard treatments. The goal is to see if the drug can help shrink tumors or slow their growth.
Guanzhou, GuangzhouAges 18–75
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,437 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.